Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1995
DOI: 10.1016/0026-0495(95)90008-x
|View full text |Cite
|
Sign up to set email alerts
|

Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
25
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(28 citation statements)
references
References 31 publications
3
25
0
Order By: Relevance
“…As it has been demonstrated that the glucagon concentration in peripheral blood showed little diurnal variation in rats [35], it was sufficient in our study to document hyperglucagonemia during fasting. Our finding of hyperglucagonemia after loss of first-pass hepatic drainage is in line with studies reporting basal or stimulated hyperglucagonemia after pancreas transplantation with systemic venous drainage [5,8,9,[37][38][39]. However, there are also a few studies which failed to find hyperglucagonemia although the grafts had systemic venous drainage [6,40].…”
Section: Discussionsupporting
confidence: 77%
“…As it has been demonstrated that the glucagon concentration in peripheral blood showed little diurnal variation in rats [35], it was sufficient in our study to document hyperglucagonemia during fasting. Our finding of hyperglucagonemia after loss of first-pass hepatic drainage is in line with studies reporting basal or stimulated hyperglucagonemia after pancreas transplantation with systemic venous drainage [5,8,9,[37][38][39]. However, there are also a few studies which failed to find hyperglucagonemia although the grafts had systemic venous drainage [6,40].…”
Section: Discussionsupporting
confidence: 77%
“…On the other hand, it reveals a close interaction between the parasympathetic and sympathetic motor nuclei, which may provide, in addition to the regulatory mechanisms at the level of the pancreas (Ahren and Taborsky, 1986;Kurose et al, 1992), the anatomic basis at the level of the CNS for the frequently observed cosecretion of insulin and glucagon (Steffens and Strubbe, 1983;Secchi et al, 1995;Taborsky et al, 1998).…”
Section: Discussionmentioning
confidence: 97%
“…Basal hyperinsulinemia was observed after pancreas transplantation in humans [34][35][36][37]. Under euglycemic conditions it was postulated that this elevation of insulin was due to an impaired insulin-insulin feedback inhibition that was neurally mediated [35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…Under euglycemic conditions it was postulated that this elevation of insulin was due to an impaired insulin-insulin feedback inhibition that was neurally mediated [35][36][37]. The most likely mediator in this mechanism was the sympathetic nervous system innervating the pancreas [34].…”
Section: Discussionmentioning
confidence: 99%